These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Haploinsufficiency for p190B RhoGAP inhibits MMTV-Neu tumor progression. Heckman-Stoddard BM; Vargo-Gogola T; McHenry PR; Jiang V; Herrick MP; Hilsenbeck SG; Settleman J; Rosen JM Breast Cancer Res; 2009; 11(4):R61. PubMed ID: 19703301 [TBL] [Abstract][Full Text] [Related]
3. Attenuated transforming growth factor beta signaling promotes metastasis in a model of HER2 mammary carcinogenesis. Novitskiy SV; Forrester E; Pickup MW; Gorska AE; Chytil A; Aakre M; Polosukhina D; Owens P; Yusupova DR; Zhao Z; Ye F; Shyr Y; Moses HL Breast Cancer Res; 2014 Oct; 16(5):425. PubMed ID: 25280532 [TBL] [Abstract][Full Text] [Related]
4. Sustained trophism of the mammary gland is sufficient to accelerate and synchronize development of ErbB2/Neu-induced tumors. Landis MD; Seachrist DD; Abdul-Karim FW; Keri RA Oncogene; 2006 Jun; 25(23):3325-34. PubMed ID: 16434967 [TBL] [Abstract][Full Text] [Related]
5. Inhibition of the mammary carcinoma angiogenic switch in C3(1)/SV40 transgenic mice by a mutated form of human endostatin. Calvo A; Yokoyama Y; Smith LE; Ali I; Shih SC; Feldman AL; Libutti SK; Sundaram R; Green JE Int J Cancer; 2002 Sep; 101(3):224-34. PubMed ID: 12209972 [TBL] [Abstract][Full Text] [Related]
6. p130Cas as a new regulator of mammary epithelial cell proliferation, survival, and HER2-neu oncogene-dependent breast tumorigenesis. Cabodi S; Tinnirello A; Di Stefano P; Bisarò B; Ambrosino E; Castellano I; Sapino A; Arisio R; Cavallo F; Forni G; Glukhova M; Silengo L; Altruda F; Turco E; Tarone G; Defilippi P Cancer Res; 2006 May; 66(9):4672-80. PubMed ID: 16651418 [TBL] [Abstract][Full Text] [Related]
7. Antitumor activity of rapamycin in a transgenic mouse model of ErbB2-dependent human breast cancer. Liu M; Howes A; Lesperance J; Stallcup WB; Hauser CA; Kadoya K; Oshima RG; Abraham RT Cancer Res; 2005 Jun; 65(12):5325-36. PubMed ID: 15958580 [TBL] [Abstract][Full Text] [Related]
9. Adiponectin deficiency limits tumor vascularization in the MMTV-PyV-mT mouse model of mammary cancer. Denzel MS; Hebbard LW; Shostak G; Shapiro L; Cardiff RD; Ranscht B Clin Cancer Res; 2009 May; 15(10):3256-64. PubMed ID: 19447866 [TBL] [Abstract][Full Text] [Related]
10. P190B RhoGAP has pro-tumorigenic functions during MMTV-Neu mammary tumorigenesis and metastasis. McHenry PR; Sears JC; Herrick MP; Chang P; Heckman-Stoddard BM; Rybarczyk M; Chodosh LA; Gunther EJ; Hilsenbeck SG; Rosen JM; Vargo-Gogola T Breast Cancer Res; 2010; 12(5):R73. PubMed ID: 20860838 [TBL] [Abstract][Full Text] [Related]
11. Epithelial and fibroblast cell lines derived from a spontaneous mammary carcinoma in a MMTV/neu transgenic mouse. Campbell MJ; Wollish WS; Lobo M; Esserman LJ In Vitro Cell Dev Biol Anim; 2002 Jun; 38(6):326-33. PubMed ID: 12513120 [TBL] [Abstract][Full Text] [Related]
12. Induction of erythropoiesis by hypoxia-inducible factor prolyl hydroxylase inhibitors without promotion of tumor initiation, progression, or metastasis in a VEGF-sensitive model of spontaneous breast cancer. Seeley TW; Sternlicht MD; Klaus SJ; Neff TB; Liu DY Hypoxia (Auckl); 2017; 5():1-9. PubMed ID: 28331872 [TBL] [Abstract][Full Text] [Related]
13. Hyperproduction of hyaluronan in neu-induced mammary tumor accelerates angiogenesis through stromal cell recruitment: possible involvement of versican/PG-M. Koyama H; Hibi T; Isogai Z; Yoneda M; Fujimori M; Amano J; Kawakubo M; Kannagi R; Kimata K; Taniguchi S; Itano N Am J Pathol; 2007 Mar; 170(3):1086-99. PubMed ID: 17322391 [TBL] [Abstract][Full Text] [Related]
14. MMTV promoter hypomethylation is linked to spontaneous and MNU associated c-neu expression and mammary carcinogenesis in MMTV c-neu transgenic mice. Zhou H; Chen WD; Qin X; Lee K; Liu L; Markowitz SD; Gerson SL Oncogene; 2001 Sep; 20(42):6009-17. PubMed ID: 11593408 [TBL] [Abstract][Full Text] [Related]
16. In vivo evidence supporting a metastasis suppressor role for Stard13 (Dlc2) in ErbB2 (Neu) oncogene induced mouse mammary tumors. Basak P; Leslie H; Dillon RL; Muller WJ; Raouf A; Mowat MRA Genes Chromosomes Cancer; 2018 Apr; 57(4):182-191. PubMed ID: 29218825 [TBL] [Abstract][Full Text] [Related]
17. Rassf3 is responsible in part for resistance to mammary tumor development in neu transgenic mice. Jacquemart IC; Springs AE; Chen WY Int J Oncol; 2009 Feb; 34(2):517-28. PubMed ID: 19148488 [TBL] [Abstract][Full Text] [Related]
18. A requirement for Nedd9 in luminal progenitor cells prior to mammary tumorigenesis in MMTV-HER2/ErbB2 mice. Little JL; Serzhanova V; Izumchenko E; Egleston BL; Parise E; Klein-Szanto AJ; Loudon G; Shubina M; Seo S; Kurokawa M; Ochs MF; Golemis EA Oncogene; 2014 Jan; 33(4):411-20. PubMed ID: 23318423 [TBL] [Abstract][Full Text] [Related]
20. A direct test of potential roles for beta3 and beta5 integrins in growth and metastasis of murine mammary carcinomas. Taverna D; Crowley D; Connolly M; Bronson RT; Hynes RO Cancer Res; 2005 Nov; 65(22):10324-9. PubMed ID: 16288021 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]